19Mar 2021

INFLAMMATORY MYOFIBROBLASTIC TUMORS IN THE PECULIAR CONTEXT OF THE POSTPARTUM CASE REPORT

  • Department of Obstetrics and Gynecology, Ibn Rochd Hospital Center, Faculty of Medicine and Pharmacy, Hassan 2 University, Casablanca, Morocco.
  • Department of Anatomopathology, Ibn Rochd Hospital Center, Faculty of Medicine and Pharmacy, Hassan 2 University, Casablanca, Morocco.
  • Abstract
  • Keywords
  • Cite This Article as
  • Corresponding Author

The debate persists about the inflammatory or tumoral, benign or malignant nature of the Inflammatory myofibroblastic tumors (TMI). Radioclinically, they can mimic a malignant neoplasm, although they are classified as intermediate by the World Health Organization (WHO). The diagnosis is almost always made by pathological examination. The treatment is poorly codified but the management is usually surgical. The removal of these tumors is a challenge when the mass is developed at the expense of or in the vicinity of noble organs. Several therapies have been tested to overcome the limitations of surgery, the results are variable. These tumors rarely affect the digestive tract. We propose the study of a case of myofibroblastic tumor developed at the expense of the omentum, five months after a cesarean section, in order to try to determine if it is a rare complication of the postpartum or a fortuitous combination.


[Khalloufi C., Ibnoulkhatib S., El Kebir A., Karkouri M., Boufettal H., Mahdaoui S. and Samouh N. (2021); INFLAMMATORY MYOFIBROBLASTIC TUMORS IN THE PECULIAR CONTEXT OF THE POSTPARTUM CASE REPORT Int. J. of Adv. Res. 9 (Mar). 607-611] (ISSN 2320-5407). www.journalijar.com


Khalloufi Chadia
Department of Obstetrics and Gynecology, Ibn Rochd Hospital Center, Faculty of Medicine and Pharmacy, Hassan 2 University, Casablanca, Morocco.
Morocco

DOI:


Article DOI: 10.21474/IJAR01/12621      
DOI URL: https://dx.doi.org/10.21474/IJAR01/12621